Praxis Precision Medicines, Inc. insider Marcio Souza reported an ownership change involving the company’s common stock on July 8, 2026. The reported transaction was not a market sale or purchase; the filing states that it was a “bona fide gift of common stock” to the Souza 2026 Trust. Because the transaction was described as a gift, the filing does not indicate sale proceeds or an open-market purchase price in the provided text. The excerpt also does not provide the number of shares transferred, the transaction code, or Souza’s beneficial ownership total after the transfer. The key reported action is therefore a transfer of Praxis common stock from Souza to a trust bearing his name, which typically reflects estate-planning or personal financial-planning activity rather than a change in investment view through a sale. The Form 4 was filed on July 8, 2026, the same date as the reported transaction. It was signed by Alex Nemiroff as attorney-in-fact for the reporting person. For investors, the filing matters because it documents a change in how an insider’s Praxis Precision Medicines holdings are held—moving shares into the Souza 2026 Trust—while not reporting a disposition for cash or an acquisition for consideration based on the information provided.